Market Closed -
Other stock markets
|
After market 06:32:26 pm | |||
167.8 USD | -1.03% | 168.8 | +0.61% |
Apr. 23 | US CDC warns of harmful reactions to fake Botox injections | RE |
Apr. 22 | Pfizer: new Emblaveo antibiotic approved in the EU | CF |
Financials (USD)
Sales 2024 * | 54.57B | Sales 2025 * | 57.78B | Capitalization | 300B |
---|---|---|---|---|---|
Net income 2024 * | 9.08B | Net income 2025 * | 11.09B | EV / Sales 2024 * | 6.48 x |
Net Debt 2024 * | 53.67B | Net Debt 2025 * | 45.01B | EV / Sales 2025 * | 5.97 x |
P/E ratio 2024 * |
30.6
x | P/E ratio 2025 * |
25.1
x | Employees | 50,000 |
Yield 2024 * |
3.69% | Yield 2025 * |
3.84% | Free-Float | 96.75% |
Latest transcript on AbbVie Inc.
1 day | +0.61% | ||
1 week | +3.24% | ||
Current month | -7.85% | ||
1 month | -5.97% | ||
3 months | +0.18% | ||
6 months | +15.94% | ||
Current year | +8.28% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 12-12-31 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 12-12-31 |
Robert Michael
PSD | President | 53 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 12-12-31 |
Edward Rapp
BRD | Director/Board Member | 66 | 12-12-31 |
Director/Board Member | 70 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.12% | 6 M€ | 0.00% | - | |
6.85% | 18 M€ | +4.24% | - | |
6.26% | 13 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 167.8 | -1.03% | 3,974,063 |
24-04-23 | 169.5 | +0.98% | 4,084,105 |
24-04-22 | 167.9 | +0.89% | 5,580,685 |
24-04-19 | 166.4 | +1.06% | 5,532,492 |
24-04-18 | 164.7 | +0.25% | 4,480,224 |
Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.28% | 300B | |
+25.61% | 672B | |
+25.87% | 570B | |
-5.24% | 360B | |
+16.49% | 321B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.75% | 149B | |
-5.21% | 147B |
- Stock Market
- Equities
- ABBV Stock